RVP Logo

Retractable Technologies, Inc. (RVP) 

AMEX
Market Cap
$22M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
123 of 776
Rank in Industry
8 of 48

Largest Insider Buys in Sector

RVP Stock Price History Chart

RVP Stock Performance

About Retractable Technologies, Inc.

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. …

Insider Activity of Retractable Technologies, Inc.

Over the last 12 months, insiders at Retractable Technologies, Inc. have bought $748,222 and sold $0 worth of Retractable Technologies, Inc. stock.

On average, over the past 5 years, insiders at Retractable Technologies, Inc. have bought $529,516 and sold $1.49M worth of stock each year.

Highest buying activity among insiders over the last 12 months: SHAW THOMAS J (PRESIDENT AND CEO) — $748,222.

The last purchase of 8,657 shares for transaction amount of $6,128 was made by SHAW THOMAS J (PRESIDENT AND CEO) on 2024‑11‑01.

List of Insider Buy and Sell Transactions, Retractable Technologies, Inc.

2024-11-01PurchasePRESIDENT AND CEO
8,657
0.0288%
$0.71$6,128+1.86%
2024-10-30PurchasePRESIDENT AND CEO
601
0.002%
$0.71$429+1.08%
2024-10-24PurchasePRESIDENT AND CEO
11,441
0.036%
$0.71$8,1800.00%
2024-10-23PurchasePRESIDENT AND CEO
21,142
0.0688%
$0.74$15,6620.00%
2024-10-18PurchasePRESIDENT AND CEO
8,104
0.0266%
$0.75$6,062-4.93%
2024-10-10PurchasePRESIDENT AND CEO
6,234
0.0215%
$0.74$4,632+0.52%
2024-10-01PurchasePRESIDENT AND CEO
5,744
0.02%
$0.75$4,319-0.85%
2024-09-25PurchasePRESIDENT AND CEO
9,663
0.0326%
$0.73$7,021-0.77%
2024-09-20PurchasePRESIDENT AND CEO
71,422
0.2524%
$0.82$58,859-2.59%
2024-09-19PurchasePRESIDENT AND CEO
27,710
0.0913%
$0.89$24,576-15.51%
2024-09-18PurchasePRESIDENT AND CEO
1,180
0.0039%
$0.89$1,051-14.65%
2024-09-16PurchasePRESIDENT AND CEO
450
0.0015%
$0.90$404-15.32%
2024-09-10PurchasePRESIDENT AND CEO
8,577
0.0289%
$0.91$7,812-15.27%
2024-09-05PurchasePRESIDENT AND CEO
5,251
0.0175%
$0.91$4,799-16.26%
2024-09-03PurchasePRESIDENT AND CEO
15,096
0.0506%
$0.92$13,937-16.34%
2024-08-27PurchasePRESIDENT AND CEO
8,747
0.029%
$0.94$8,248-18.75%
2024-08-26PurchasePRESIDENT AND CEO
134
0.0004%
$0.94$127-18.71%
2024-08-15PurchasePRESIDENT AND CEO
3,652
0.0116%
$0.99$3,6150.00%
2024-08-14PurchasePRESIDENT AND CEO
13,924
0.0447%
$1.00$13,9340.00%
2024-08-05PurchasePRESIDENT AND CEO
15,458
0.0504%
$0.99$15,252-11.14%

Insider Historical Profitability

85.84%
SHAW THOMAS JPRESIDENT AND CEO
14815493
49.4886%
$0.744730+87.91%
Leonard Braden Michaeldirector
688575
2.3001%
$0.7453<0.0001%
Laterza Marcodirector
10000
0.0334%
$0.7410<0.0001%
Findley Darren Edirector
4200
0.014%
$0.7410+96.84%
KUHLMAN RUSSELL BVP - Sales
0
0%
$0.7413

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$838,730.002.34698,9410%+$0<0.0001
Renaissance Technologies$431,000.001.2358,893+44.38%+$132,483.75<0.01
BlackRock$329,520.000.92274,599-0.85%-$2,833.21<0.0001
Bridgeway Capital Management$179,441.000.5149,5340%+$0<0.01
Geode Capital Management$164,633.000.46137,1730%+$0<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.